Patents by Inventor Rosario SALVADOR

Rosario SALVADOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220160745
    Abstract: Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside, pterostilbene and a phosphodiesterase (PDE) inhibitor, including a PDE4 inhibitor such as ibudilast, and also including a thiol/cysteine donor, such as acetylcysteine.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 26, 2022
    Inventors: José María ESTRELA ARIGÜEL, María Elena OBRADOR PLA, Rosario SALVADOR, Ryan W. DELLINGER
  • Patent number: 11179348
    Abstract: The present invention relates to a combination comprising pterostilbeneor pterostilbene phosphate or a pharmaceutically acceptable salt thereof, a glutathione depleting agent and a cancer chemotherapeutic agent. The invention also relates to the medical use of this combination, in particular for the treatment and/or prevention of cancer.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: November 23, 2021
    Assignees: FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR, UNIVERSITAT DE VALÈNCIA—ESTUDI GENERAL, FUNDACIÓ INVESTIGACIÓ HOSPITAL GENERAL UNIVERSITARI DE VALÈNCIA PER A LA INVESTIGACIÓ BIOMÈDICA I CIÈNCIES DE LA SALUT, IDCQ HOSPITALES Y SANIDAD, S.L.U.
    Inventors: José María Estrela Arigüel, María Benlloch García, María Elena Plá Obrador, Lilian Soraya Vallés Martín, María Lucía Rodríguez Romero, Joan Antoni Sirerol Talens, Javier Luis Alcácer García, José Alfredo Pellicer Artés, Rosario Salvador Palmer, Guillermo María Sáez Tormo, Concepción Cerdá Micó
  • Publication number: 20180214390
    Abstract: The present invention relates to a combination comprising pterostilbeneor pterostilbene phosphate or a pharmaceutically acceptable salt thereof, a glutathione depleting agent and a cancer chemotherapeutic agent. The invention also relates to the medical use of this combination, in particular for the treatment and/or prevention of cancer.
    Type: Application
    Filed: June 9, 2016
    Publication date: August 2, 2018
    Inventors: José María ESTRELA ARIGÜEL, María BENLLOCH GARCÍA, María Elena PLÁ OBRADOR, Lilian Soraya VALLÉS MARTÍN, María Lucía RODRÍGUEZ ROMERO, Joan Antoni SIREROL TALENS, Javier Luis ALCÁCER GARCÍA, José Alfredo PELLICER ARTÉS, Rosario SALVADOR PALMER, Guillermo María SÁEZ TORMO, Concepción CERDÁ MICÓ